For patients whose primary goal is visceral fat reduction, we use Tesamorelin, which is FDA-approved for that specific indication and has stronger clinical data for fat metabolism than sermorelin
Patients may discuss: Medication access Insurance coverage Self-pay options Side effects and treatment expectations Long-term weight management goals Serving Patients Across New York Queens Brooklyn Bronx Manhattan Staten Island Long Island Buffalo Rochester Albany Syracuse Yonkers White Plains New Rochelle Hempstead Insurance Verification & Self-Pay Options GoalBMI Wellness helps eligible patients understand available treatment pathways before starting semaglutide therapy
In type 2 diabetes, the incretin effect is diminished and in parallel, post-prandial insulin secretion is deteriorating (2, 5)
If you have a diagnosis of cancer, you and your healthcare professional will discuss the next steps when it comes to the medications you currently take
Weight-loss results are self-reported, not typical, and vary based on starting weight, adherence, and individual health
Long-term pharmacovigilance continues to monitor for any emerging signals